Interleukin 33 (IL33) Antibody (Biotin)

Este producto es parte de IL33 - Interleukin 33
Interleukin 33 (IL33) Antibody (Biotin)
377€ (200 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Interleukin 33 (IL33) Antibody (Biotin)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx271511
Tested Applications
WB

Description

Interleukin 33 (IL33) Antibody (Biotin) is a Rabbit Polyclonal antibody conjugated to Biotin against Interleukin 33 (IL33).

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Interleukin 33 (IL33)
Host
Rabbit
Reactivity
Mouse
Recommended Dilution
WB: 0.5-2 µg/ml, IHC (Predicted): 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Biotin
Isotype
IgG
Purification
Purified by antigen-specific affinity chromatography.
Size 1
200 µl
Size 2
1 ml
Form
Liquid
Tested Applications
WB
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
IL33,IL-33,C9orf26,IL1F11,IL-1F11
Background
Antibody anti-IL33
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

IL33 is a nuclear alarmin cytokine belonging to the IL-1 family, released during cellular stress, injury, or necrosis to alert the immune system and promote inflammation. IL33 binds to its receptor IL1RL1 (ST2) and forms a signaling complex with IL1RAP, leading to activation of NF-κB and MAPK pathways, which drive cytokine production, immune cell activation, and tissue repair. IL33 primarily targets type 2 immune cells, including Th2 cells, innate lymphoid cells (ILC2s), mast cells, and eosinophils, to regulate allergic inflammation, tissue homeostasis, and anti-helminth immunity. It is abundantly expressed in epithelial cells, endothelial cells, and fibroblasts, where it functions as both a cytokine and a transcriptional regulator. Dysregulated IL33 signaling contributes to allergic diseases, such as asthma, atopic dermatitis, and rhinitis, as well as inflammatory and fibrotic disorders. In tumors, IL33 can promote both pro- and anti-tumor immune responses depending on the context. Knockout studies reveal reduced type 2 cytokine production, impaired tissue repair, and weakened immune responses, highlighting IL33’s role in inflammation, tissue homeostasis, and immunity.

Productos relacionados

abx027997

Interleukin 33 (IL33) Antibody

Cytokine that binds to and signals through IL1RL1/ST2 and its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, follo…

Ver producto
abx067523

Human Interleukin 33 (IL33) Protein

Human Interleukin 33 (IL33) is a recombinant Human protein expressed in E. coli.…

Ver producto
abx067524

Mouse Interleukin 33 (IL33) Protein

Mouse Interleukin 33 (IL33) is a recombinant Mouse protein expressed in E. coli.…

Ver producto